Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.75 | -$0.75 | -$0.75 |
Q2 2025 | 1 | -$0.45 | -$0.45 | -$0.45 |
Q3 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
Q4 2025 | 1 | $0.30 | $0.30 | $0.30 |
OptiNose, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $0.00268 earnings per share for the quarter, topping analysts' consensus estimates of $-0.05 by $0.05268. The company had revenue of 20.44 M for the quarter and had revenue of 70.99 M for the year. OptiNose, Inc. has generated $0 earnings per share over the last year ($-0.32 diluted earnings per share) and currently has a price-to-earnings ratio of -30.05. OptiNose, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/12/2024 | Q3 2024 | -$0.05 | $0.00 | 0.05 | $22.95 M | $20.44 M |
08/08/2024 | Q2 2024 | -$1.20 | -$0.05 | 1.15 | $20.58 M | $20.49 M |
05/14/2024 | Q1 2024 | -$1.50 | -$0.12 | 1.38 | N/A | $14.88 M |
03/07/2024 | Q4 2023 | -$1.50 | -$0.09 | 1.41 | N/A | $19.87 M |
11/09/2023 | Q3 2023 | -$1.50 | -$0.08 | 1.42 | $18.68 M | $19.82 M |
08/10/2023 | Q2 2023 | -$1.65 | $0.02 | 1.67 | $17.36 M | $19.45 M |
05/11/2023 | Q1 2023 | -$2.40 | -$0.17 | 2.23 | N/A | $11.85 M |
03/07/2023 | Q4 2022 | -$2.40 | -$0.18 | 2.22 | N/A | $20.86 M |
11/10/2022 | Q3 2022 | -$2.55 | -$0.18 | 2.37 | $23.35 M | $20.08 M |
08/11/2022 | Q2 2022 | -$3.30 | -$0.23 | 3.07 | $20.55 M | $20.58 M |
05/12/2022 | Q1 2022 | -$3.60 | -$0.31 | 3.29 | N/A | $14.76 M |
03/08/2022 | Q4 2021 | -$3.30 | -$0.23 | 3.07 | N/A | $22.51 M |
11/15/2021 | Q3 2021 | -$5.55 | -$0.32 | 5.23 | $23.50 M | $21.83 M |
08/11/2021 | Q2 2021 | -$6.45 | -$0.44 | 6.01 | $18.08 M | $18.36 M |
05/05/2021 | Q1 2021 | -$7.80 | -$0.49 | 7.31 | N/A | $11.96 M |
03/03/2021 | Q4 2020 | -$6.75 | -$0.46 | 6.29 | N/A | $16.35 M |
11/05/2020 | Q3 2020 | -$8.40 | -$0.43 | 7.97 | $14.58 M | $15.44 M |
08/04/2020 | Q2 2020 | -$7.65 | -$0.56 | 7.09 | $9.79 M | $10.27 M |
05/07/2020 | Q1 2020 | -$9.90 | -$0.63 | 9.27 | N/A | $7.06 M |
03/05/2020 | Q4 2019 | -$10.04 | -$0.58 | 9.46 | N/A | $11.08 M |
OptiNose, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based offlast year's report dates.
In the previous quarter, OptiNose, Inc. (:OPTN) reported $0.00268 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.05 by $0.05268.
The conference call for OptiNose, Inc.'s latest earnings report can be listened to online.
The conference call transcript for OptiNose, Inc.'s latest earnings report can be read online.
OptiNose, Inc. (:OPTN) has a recorded annual revenue of $70.99 M.
OptiNose, Inc. (:OPTN) has a recorded net income of $-35,483,000.OptiNose, Inc. has generated $-0.32 earnings per share over the last four quarters.
OptiNose, Inc. (:OPTN) has a price-to-earnings ratio of -30.05 and price/earnings-to-growth ratio is -1.28.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED